This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
B A C K G R O U N D

Description of the condition
Idiopathic toe walking (ITW) is a diagnosis given to healthy children who persist in walking on their tiptoes after they should typically achieve a heel-toe gait. The estimated prevalence of ITW varies from 5% to 12% of healthy children (Engström 2012b), and commonly affects boys more than girls (Bernhard 2005; Engelbert 2011) .
Children progress through a number of stages when learning to walk. Toddlers initially walk with stilted leg shuffling, then cruise around furniture before starting to walk flat-footed. As children mature, they walk with a heel-toe gait (Hallemans 2003; Norlin 1981) , which comprises three distinct phases: initial heel strike, midfoot contact, and toe-o . During the development of heel-toe gait, some children walk on their tiptoes. However, toe walking is not a mandatory stage that all children will progress through and heel strike is present in most children by the age of 18 months (Sutherland 1980) . A toe walking gait is described by authors as a normal variant in motor development for healthy children up to the age of 18 months (Sala 1999; Sutherland 1980) , two years (Fox 2006; Hemo 2006; Stricker 1998) , five years (Westberry 2008) , and even until seven years of age (Kalen 1986) . Some children continue to walk on their toes and parents are encouraged to seek advice from health professionals when toe walking persists. However, a lack of consensus remains on when to seek advice.
ITW is an exclusionary diagnosis given to otherwise healthy children who continue to toe walk. Many conditions are associated with a toe walking gait and exclusion of these often make the diagnosis of ITW challenging for health professionals (Engelbert 2011; . Toe walking may result from an inability to make heel strike due to an underlying neurological or neuromuscular disease. Conditions commonly associated with a toe walking gait include cerebral palsy (Wren 2010) , muscular dystrophy (Hyde 2000) , and orthopaedic problems, such as congenital talipes equinus (Caselli 1988) . Toe walking is also commonly observed in children with autistic spectrum disorders (Barrow 2011; Ming 2007) , and in children with intellectual disabilities and developmental speech and language disorders (Accardo 1989; Accardo 1992) .
Persistent toe walking in healthy children was first defined by Hall 1967 as "congenital short tendo calcaneus". This definition was given because the population in this study demonstrated Achilles tendon tightness. This diagnosis was later changed to 'habitual toe walking' (Griffin 1977) , and subsequently the term 'idiopathic toe walking' was introduced in 1980 (Conrad 1980). Most authors agree that ITW is a diagnosis of exclusion, made when children persist in walking on their toes with no signs of a neurologic, orthopaedic, or psychological condition (Armand 2006; Brouwer 2000; Eastwood 1997; Engstrom 2010; Griffin 1977; Hall 1967; Hemo 2006; Hicks 1988; Hirsch 2004; Kalen 1986; Kogan 2001; McMulkin 2006; Papariello 1985; Pendharkar 2012; Solan 2010; Stott 2004; .
The aetiology of ITW continues to be investigated. Many theories exist as to why healthy children continue to toe walk, including a hereditary genetic disorder with an autosomal dominant pattern of inheritance with variable expression (Katz 1984) , an increase in the proportion of type I muscle fibres (Eastwood 1997), sensory processing difficulties (Williams 2012) , and the use of infant walkers (Engelbert 1999) . Some authors describe children with ITW as having the ability to walk with a heel strike, but preferring to walk on their toes (Crenna 2005; , and children who have ITW gait often also have limited ankle dorsiflexion (Brouwer 2000; Hall 1967; Hicks 1988; Williams 2013a) .
The consequences of persistent and untreated toe walking are unclear. Untreated toe walking may lead to a higher chance of tripping or falling (Caselli 1988), or have a social or cosmetic impact (Gormley 1997; Pendharkar 2008) ; however, these statements are not based on systematic observations. Many authors believe intervention for ITW should be undertaken to improve any restriction in ankle range of motion, and that if no treatment is undertaken, children with ITW are at a greater chance of developing more severe limitations in this range (Bernhard 2005; Brunt 2004; Gormley 1997; Hemo 2006; Sobel 1997) . However, no longitudinal studies support this supposition. On the contrary, one study that followed 80 children, of whom 48 did not receive active intervention (but underwent observation, wore modified footwear, or performed gastrocnemius and soleus stretching exercises under parental or healthcare professional supervision) concluded that persistent toe walking did not result in significant functional disturbance, foot deformities, or pain (Stricker 1998) . Similarly, Hirsch 2004 found, in a study involving a small number (N = 11) of adolescents and adults, limited long-term structural impact of toe walking, with a small percentage continuing to toe walk in the long term (N = 3, 27%). Taussig 2001 also found a spontaneous correction of ITW associated with age in 32 out of 41 children aged between three and eight years. This evidence has led authors to postulate that ITW is a benign condition that resolves spontaneously in most instances and causes a child (but not necessarily their parents) little concern while it lasts. Researchers have studied many types of conservative interventions, including observation (Eastwood 2000; Ei 2006; Stricker 1998) , muscle stretching exercise programmes targeting gastrocnemius, soleus, or both (Stricker 1998) 
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How the intervention might work
Apart from simple observation, most interventions aim to lengthen the Achilles tendon, increase dorsiflexion of the ankle joint, and thereby facilitate a typical heel-toe gait pattern. Other interventions have aimed to inhibit the gait pattern, facilitate heel contact, and challenge the sensory system of the child. A short description of the mechanisms behind interventions for ITW follows.
• Observation (regular review) is used to monitor any developing limitation in ankle dorsiflexion (Ei 2006) , and identify the need for intervention. • Stretching exercises are often prescribed in the presence of reduced ankle dorsiflexion. The Cochrane Review on 'Stretch for the treatment and prevention of contractures' describes the general theory of stretching and presents detailed evidence (Katalinic 2010). • Ankle-foot-orthoses, full-length foot orthoses, footwear, and serial casts may prolong the time of a stretching intervention (according to the theory about stretching presented by Katalinic 2010). These devices may also physically inhibit the child from getting up on their tiptoes. These interventions are commonly used in children with good ankle dorsiflexion range of motion for gait re-education, motor control, or both (Brouwer 2000). • Motor control intervention is based on the premise that a toewalking gait in children older than three years may be due to motor control deficiency (Clark 2010). The motor control intervention aims to facilitate an erect standing and walking posture, and to secure a ground reaction force relative to the ankle axis. • Augmented auditory feedback is a device that produces an auditory signal when the foot-switch is closed on heel contact (Conrad 1980) . The device aims to establish a normal muscle response and heel strike gait. • Footwear therapy utilises footwear with a rigid sole and straight last (Caselli 2002) . This shoe design is thought to limit dorsiflexion at the metatarsal-phalangeal joint and thereby prevent toe walking. • Different flooring surfaces have been utilised to challenge sensory processing abilities with different plantar tactile input (Fanchiang 2016 consists of an incision of the gastrocnemius and, commonly, also the soleus fascia. The Baker procedure is a variation of the Vulpius procedure with the gastrocnemius fascia cut in a tongue-and-groove fashion instead of more transversely (Yngve 1996) .
Why it is important to do this review
This systematic review is required to evaluate the evidence for any intervention for the treatment of ITW. The conclusions of this review may guide clinicians in tailoring care for children with ITW. As many of the treatments employed have financial implications for parents or healthcare services, this review also aims to highlight any deficits in the current research base.
O B J E C T I V E S
To assess the effects of conservative and surgical interventions on gait normalisation, ankle range of motion, and pain in children with idiopathic toe walking (ITW), identifying adverse effects of the interventions and the frequency of recurrence.
M E T H O D S
Criteria for considering studies for this review
Types of studies
This systematic review will include randomised controlled trials (RCTs) and quasi-RCTs (using methods of allocation which are not strictly random, for example, hospital numbers or date of birth).
Types of participants
Any study involving participants diagnosed with ITW gait in the absence of a medical condition known to cause toe walking, or be associated with toe walking. As there is no universally accepted age group for ITW, this review includes ITW at any age, who have been toe walking for more than six months, who can and cannot walk with a heel-toe gait, and who may or may not have limited dorsiflexion of the ankle joint (a definition based on Eastwood 1997 , Hemo 2006 , Hirsch 2004 , Kalen 1986 , Kogan 2001 , McMulkin 2006 , Sala 1999 , Stricker 1998 , Stott 2004 , and Westberry 2008 .
Types of interventions
We will define conservative treatment as watchful waiting, stretching exercises (guided either by a health professional within the clinical setting and implemented within the home environment), footwear, orthoses, serial casting (with or without botulinum toxin treatment), botulinum toxin treatment (with or without serial casting), external stimulation aimed at tactile input, and feedback devices in footwear. Surgical interventions are operationally defined as all percutaneous and open procedures aimed at improving dorsiflexion of the ankle joint and regaining a typical heel-toe gait pattern. We will consider comparisons of any intervention versus another, or versus no intervention (or watchful waiting).
Types of outcome measures
These are outcomes of interest in whichever studies are included but we will not use them as criteria for selecting studies for the review.
Primary outcomes
The primary outcome will be the improvement (majority or greater than 50%) of time spent toe walking, measured by either quantifiable judgement from the child, parent, or healthcare professional, or by kinetic or kinematic gait analysis. Time frame: six months. 
Search methods for identification of studies Electronic searches
We will search the Cochrane Neuromuscular Specialised Register, the Cochrane Central Register of Controlled Trials (the current issue of the Cochrane Library), MEDLINE (1966 to the present), Embase (1980 to the present), CINAHL Plus (1937 to the present), PEDro (1929 to the present). The MEDLINE strategy is given in Appendix 1.
We will search registers of clinical trials for ongoing and recently completed trials: the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP, apps.who.int/trialsearch), the metaRegister of Controlled Trials (mRCT, controlled-trials.com/mrct), and ClinicalTrials.gov (clinicaltrials.gov). We will search conference proceedings and other grey literature in the BIOSIS databases and System for Information on Grey Literature in Europe (OpenGrey, opengrey.eu). We will search guidelines via the Turning Research into Practice database (TRIP, tripdatabase.com) and National Guideline Clearinghouse (guideline.gov). We will not apply language restrictions or restriction of search strategy to specific trial designs.
Searching other resources
We will check reference lists of included studies and journals citing the article. We will contact trial authors to identify any additional published or unpublished data.
We will contact experts in the field and trial authors for ongoing trials. There will be no limitations as to publication status (i.e. published or unpublished) or language.
Data collection and analysis
Selection of studies
Two review authors (AC and PbD) will independently screen titles and abstracts of the citations from the literature search to determine if they meet inclusion criteria. We will obtain the full-text of studies that possibly or definitely fulfil our criteria according to the abstract. We will resolve disagreements through discussion and when necessary, consult a third review author (CW). We will arrange translation of trials published in languages other than English and Dutch. We will document the study selection process in sufficient detail to complete a PRISMA flow diagram (Moher 2009 ).
We will give details of reasons for exclusion of studies that appear eligible, but which fail to meet our criteria in a 'Characteristics of excluded studies' table.
Data extraction and management
Two review authors (CW and KG) will carry out the data extraction independently. They will resolve discrepancies through discussion and when necessary, consult a third review author (VP). The review authors will use a standard data extraction form. Because of the diversity of potentially eligible studies and the ways in which they are reported, we may develop the data collection form further in the course of reviewing a sample of primary studies. We will use the form to record: information on eligibility of the study in relation to the research question, information on the methods, the population, the intervention, comparison interventions, the outcomes, the results, any adverse events, and miscellaneous information (such as funding and conflicts of interest). One review author (CW) will enter data into the Cochrane authoring and statistical software Review Manager 5 (RevMan 2014). A second review author (RE) will check the accuracy of the outcome data entry and spotcheck study characteristics against trial reports.
We will document the outcome of efforts to obtain missing information from trial authors.
Assessment of risk of bias in included studies
Two review authors (VP and RE) will independently assess the risk of bias in included studies using the Cochrane 'Risk of bias' tool for each different outcome (Higgins 2011). We will resolve disagreements through discussion and, when necessary, consult a third review author (CW). We will attempt to obtain the information necessary for 'Risk of bias' assessment from the trial authors if it is not available in published reports. We will report the source of any such information in the review.
We will assess the risk of bias according to the following domains:
1. random sequence generation; 2. allocation concealment; 3. blinding of participants and personnel; 4. blinding of outcome assessment; 5. incomplete outcome data; 6. selective outcome reporting; and 7. other bias.
We will grade each potential source of bias as high, low or unclear and provide a quote from the study report together with a justification for our judgment in the 'Risk of bias' table. We will summarise the risk of bias judgements across different studies for each of the domains listed.
Assessment of bias in the review process
We will conduct the review according to this protocol and report any deviations from it in the 'Differences between protocol and review' section of the published review.
Measures of treatment e ect
Continuous outcomes: changes in amount of toe walking to heeltoe gait for participants will comprise the main outcomes. If the same measurement instrument or scale is used across studies, we will use the mean difference (MD) to pool and compare post-treatment mean scores, with the weight given to each study determined by the precision of the estimate of effect. If different instruments or scales are used across studies, we will calculate the standardised mean difference (SMD) with a 95% confidence interval (CI) to pool and compare post-treatment mean scores.
As a rule of thumb for the interpretation of Cohen's SMD, we will use the criteria discussed in Higgins 2011 in the Cochrane Handbook for Systematic Reviews of Interventions:
• < 0.40: small effect;
• 0.40 to 0.70: moderate effect; and • > 0.70: large effect.
For dichotomous outcomes, we will calculate a risk ratio (RR) with a 95% CI.
Unit of analysis issues
Randomisation will need to be conducted at the level of the individual, as study outcomes will be assessed per participant not per foot. Where data on individual feet are reported, we will seek appropriate statistical analysis to assess and account for any correlation between feet. We will include cluster-randomised trials only when the intervention and control groups are totally comparable except for location and recruitment. In addition, we will include cross-over trials when all participants have received the interventions in a sequence with the participant then acting as their own control.
Dealing with missing data
We will contact trial authors to gather or clarify missing data. If we are unable to obtain these data, we will describe strategies for imputing missing data and assess the effects of these in sensitivity analyses.
Assessment of heterogeneity
We will assess heterogeneity by visual inspection of the forest plots, and the I statistic. We will define significant heterogeneity as I > 50% because this may represent substantial or considerable heterogeneity (Higgins 2011).
Assessment of reporting biases
If there are more than 10 trials in a single analysis, we will create funnel plots to assess publication bias; we will interpret this with caution.
Data synthesis
We will use the Review Manager 5 for data analysis and follow the guidelines of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011; RevMan 2014). We will use a fixed-effect analysis and perform a sensitivity analysis using a random-effects model if there is evidence of significant statistical heterogeneity. When a meta-analysis cannot be performed, we will describe the effects of interventions narratively in a qualitative synthesis.
Summary of findings and GRADE
We will create a 'Summary of findings' table using the following outcomes: disturbed gait pattern, limitation in range of motion of the ankle joint, pain, percentage of time toe walking, recurrence of ITW, and adverse effects. We will use the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence (studies that contribute data for the prespecified outcomes) (Atkins 2004). We will use methods and recommendations described in Section 8.5 and Chapter 12 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), using GRADEproGDT software (GRADEpro GDT). We will justify all decisions to down-or upgrade the quality of studies using footnotes, and we will include comments to aid readers' understanding of the evidence grading where necessary.
Subgroup analysis and investigation of heterogeneity
Where possible, we will conduct subgroup analyses for the severity of contracture (range of joint motion of dorsiflexion of the ankle joint of more than 10°, 0° to 10°, and less than 0°). We will use ITW gait pattern as the outcome measure for subgroup analyses and use the formal test for subgroup interactions in Review Manager 5 (RevMan 2014).
Sensitivity analysis
We will consider sensitivity analyses during the review process, and if required we will:
1. repeat the analysis, excluding unpublished studies (if there are any); 2. repeat the analysis, excluding studies at high risk of bias; 3. repeat the analysis if there is one or more very large study/studies, excluding them to look at how much they dominate the results; 4. repeat the analysis to assess the effects of imputing missing data.
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